Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Human Coagulation Factor VII Industry Research Report, Growth Trends and Competitive Analysis 2024-2030

Global Human Coagulation Factor VII Industry Research Report, Growth Trends and Competitive Analysis 2024-2030

Industry: Pharma & Healthcare

Published: 2024-04-17

Pages: 118 Pages

Report ld: 2697328

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activated factor VII is also available, but does not play any considerable role in the market.

The global Human Coagulation Factor VII market size was US$ 2282.4 million in 2023 and is forecast to a readjusted size of US$ 4368 million by 2030 with a CAGR of 9.6% during the forecast period 2024-2030.

Human Coagulation Factor VII Market Size

M= millions and B=billions

Europe and North America are the largest region of Human Coagulation Factor VII, with about 40% market share respectively. NovoNordisk is the major manufacturer of industry.

In terms of sales (consumption) side, this report focuses on the sales of Human Coagulation Factor VII by regions (Countries), company, by type and by type. from 2019 to 2024 and forecast to 2030.

The global Human Coagulation Factor VII market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Human Coagulation Factor VII market. These figures have been provided in terms of both revenue and sales for the period 2019-2030. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.

Market Segmentation

Report Metric
Details
Report Title
Global Human Coagulation Factor VII Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Forecasted Market Size in 2030
US$ 4368 million
CAGR(2024-2030)
9.6%
Market Size Available for Years
2019-2030
Global Human Coagulation Factor VII Companies Covered
NovoNordisk
Global Human Coagulation Factor VII Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Coagulation Factor VII Market, Segment by Type
Recombinant Factor VIII

Plasma-derived Factor VIII
Global Human Coagulation Factor VII Market, Segment by Application
Hemophilia A

Spontanous / Trauma

Surgical

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Human Coagulation Factor VII in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Human Coagulation Factor VII manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7: Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8: China by company, by type and by application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Coagulation Factor VII sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

 1 Report Overview
    1.1 Human Coagulation Factor VII Definition
    1.2 Market by Type
        1.2.1 Global Human Coagulation Factor VII Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
        1.2.2 Recombinant Factor VIII
        1.2.3 Plasma-derived Factor VIII
    1.3 Market Segment by Application
        1.3.1 Global Human Coagulation Factor VII Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
        1.3.2 Hemophilia A
        1.3.3 Spontanous / Trauma
        1.3.4 Surgical
        1.3.5 Others
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Global Human Coagulation Factor VII Sales
    2.1 Global Human Coagulation Factor VII Revenue Estimates and Forecasts 2019-2030
    2.2 Global Human Coagulation Factor VII Revenue by Region: 2019 VS 2023 VS 2030
    2.3 Global Human Coagulation Factor VII Revenue by Region
        2.3.1 Global Human Coagulation Factor VII Revenue by Region (2019-2024)
        2.3.2 Global Human Coagulation Factor VII Revenue by Region (2025-2030)
    2.4 Global Human Coagulation Factor VII Sales Quantity Estimates and Forecasts 2019-2030
    2.5 Global Human Coagulation Factor VII Sales Quantity by Region: 2019 VS 2023 VS 2030
    2.6 Global Human Coagulation Factor VII Sales Quantity by Region
        2.6.1 Global Human Coagulation Factor VII Sales Quantity by Region (2019-2024)
        2.6.2 Global Human Coagulation Factor VII Sales Quantity by Region (2025-2030)
    2.7 North America
    2.8 Europe
    2.9 China
    2.10 APAC (excluding China)
    2.11 Middle East, Africa and Latin America

 3 Competition by Manufacturers
    3.1 Global Human Coagulation Factor VII Sales Quantity by Manufacturers
        3.1.1 Global Human Coagulation Factor VII Sales Quantity by Manufacturers (2019-2024)
        3.1.2 Global Human Coagulation Factor VII Sales Quantity Share by Manufacturers (2019-2024)
        3.1.3 Global Top 10 and Top 5 Companies by Human Coagulation Factor VII Sales in 2023
    3.2 Global Human Coagulation Factor VII Revenue by Manufacturers
        3.2.1 Global Human Coagulation Factor VII Revenue by Manufacturers (2019-2024)
        3.2.2 Global Human Coagulation Factor VII Revenue Share by Manufacturers (2019-2024)
        3.2.3 Global Top 10 and Top 5 Companies by Human Coagulation Factor VII Revenue in 2023
    3.3 Global Human Coagulation Factor VII Sales Price by Manufacturers
    3.4 Global Key Players of Human Coagulation Factor VII, Industry Ranking, 2022 VS 2023
    3.5 Analysis of Competitive Landscape
        3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.5.2 Global Human Coagulation Factor VII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.6 Global Key Manufacturers of Human Coagulation Factor VII, Manufacturing Base Distribution and Headquarters
    3.7 Global Key Manufacturers of Human Coagulation Factor VII, Product Offered and Application
    3.8 Global Key Manufacturers of Human Coagulation Factor VII, Date of Enter into This Industry
    3.9 Mergers & Acquisitions, Expansion Plans

 4 Estimates and Forecasts by Type
    4.1 Global Human Coagulation Factor VII Sales Quantity by Type
        4.1.1 Global Human Coagulation Factor VII Historical Sales Quantity by Type (2019-2024)
        4.1.2 Global Human Coagulation Factor VII Forecasted Sales Quantity by Type (2025-2030)
        4.1.3 Global Human Coagulation Factor VII Sales Quantity Market Share by Type (2019-2030)
    4.2 Global Human Coagulation Factor VII Revenue by Type
        4.2.1 Global Human Coagulation Factor VII Historical Revenue by Type (2019-2024)
        4.2.2 Global Human Coagulation Factor VII Forecasted Revenue by Type (2025-2030)
        4.2.3 Global Human Coagulation Factor VII Revenue Market Share by Type (2019-2030)
    4.3 Global Human Coagulation Factor VII Price by Type
        4.3.1 Global Human Coagulation Factor VII Price by Type (2019-2024)
        4.3.2 Global Human Coagulation Factor VII Price Forecast by Type (2025-2030)

 5 Market Size by Application
    5.1 Global Human Coagulation Factor VII Sales Quantity by Application
        5.1.1 Global Human Coagulation Factor VII Historical Sales Quantity by Application (2019-2024)
        5.1.2 Global Human Coagulation Factor VII Forecasted Sales Quantity by Application (2025-2030)
        5.1.3 Global Human Coagulation Factor VII Sales Quantity Market Share by Application (2019-2030)
    5.2 Global Human Coagulation Factor VII Revenue by Application
        5.2.1 Global Human Coagulation Factor VII Historical Revenue by Application (2019-2024)
        5.2.2 Global Human Coagulation Factor VII Forecasted Revenue by Application (2025-2030)
        5.2.3 Global Human Coagulation Factor VII Revenue Market Share by Application (2019-2030)
    5.3 Global Human Coagulation Factor VII Price by Application
        5.3.1 Global Human Coagulation Factor VII Price by Application (2019-2024)
        5.3.2 Global Human Coagulation Factor VII Price Forecast by Application (2025-2030)

 6 North America
    6.1 North America Human Coagulation Factor VII Sales by Company
        6.1.1 North America Human Coagulation Factor VII Revenue by Company (2019-2024)
        6.1.2 North America Human Coagulation Factor VII Sales Quantity by Company (2019-2024)
    6.2 North America Human Coagulation Factor VII Market Size by Type
        6.2.1 North America Human Coagulation Factor VII Sales Quantity by Type (2019-2030)
        6.2.2 North America Human Coagulation Factor VII Revenue by Type (2019-2030)
    6.3 North America Human Coagulation Factor VII Market Size by Application
        6.3.1 North America Human Coagulation Factor VII Sales Quantity by Application (2019-2030)
        6.3.2 North America Human Coagulation Factor VII Revenue by Application (2019-2030)
    6.4 North America Human Coagulation Factor VII Market Size by Country
        6.4.1 North America Human Coagulation Factor VII Revenue by Country: 2019 VS 2023 VS 2030
        6.4.2 North America Human Coagulation Factor VII Revenue by Country (2019-2030)
        6.4.3 North America Human Coagulation Factor VII Sales Quantity by Country (2019-2030)
        6.4.4 U.S.
        6.4.5 Canada

 7 Europe
    7.1 Europe Human Coagulation Factor VII Sales by Company
        7.1.1 Europe Human Coagulation Factor VII Sales Quantity by Company (2019-2024)
        7.1.2 Europe Human Coagulation Factor VII Revenue by Company (2019-2024)
    7.2 Europe Human Coagulation Factor VII Market Size by Type
        7.2.1 Europe Human Coagulation Factor VII Sales Quantity by Type (2019-2030)
        7.2.2 Europe Human Coagulation Factor VII Revenue by Type (2019-2030)
    7.3 Europe Human Coagulation Factor VII Market Size by Application
        7.3.1 Europe Human Coagulation Factor VII Sales Quantity by Application (2019-2030)
        7.3.2 Europe Human Coagulation Factor VII Revenue by Application (2019-2030)
    7.4 Europe Human Coagulation Factor VII Market Size by Country
        7.4.1 Europe Human Coagulation Factor VII Revenue by Country: 2019 VS 2023 VS 2030
        7.4.2 Europe Human Coagulation Factor VII Revenue by Country (2019-2030)
        7.4.3 Europe Human Coagulation Factor VII Sales Quantity by Country (2019-2030)
        7.4.4 Germany
        7.4.5 France
        7.4.6 U.K.
        7.4.7 Italy
        7.4.8 Russia

 8 China
    8.1 China Human Coagulation Factor VII Sales by Company
        8.1.1 China Human Coagulation Factor VII Sales Quantity by Company (2019-2024)
        8.1.2 China Human Coagulation Factor VII Revenue by Company (2019-2024)
    8.2 China Human Coagulation Factor VII Market Size by Type
        8.2.1 China Human Coagulation Factor VII Sales Quantity by Type (2019-2030)
        8.2.2 China Human Coagulation Factor VII Revenue by Type (2019-2030)
    8.3 China Human Coagulation Factor VII Market Size by Application
        8.3.1 China Human Coagulation Factor VII Sales Quantity by Application (2019-2030)
        8.3.2 China Human Coagulation Factor VII Revenue by Application (2019-2030)

 9 APAC (excluding China)
    9.1 APAC Human Coagulation Factor VII Sales by Company
        9.1.1 APAC Human Coagulation Factor VII Sales Quantity by Company (2019-2024)
        9.1.2 APAC Human Coagulation Factor VII Revenue by Company (2019-2024)
    9.2 APAC Human Coagulation Factor VII Market Size by Type
        9.2.1 APAC Human Coagulation Factor VII Sales Quantity by Type (2019-2030)
        9.2.2 APAC Human Coagulation Factor VII Revenue by Type (2019-2030)
    9.3 APAC Human Coagulation Factor VII Market Size by Application
        9.3.1 APAC Human Coagulation Factor VII Sales Quantity by Application (2019-2030)
        9.3.2 APAC Human Coagulation Factor VII Revenue by Application (2019-2030)
    9.4 APAC Human Coagulation Factor VII Market Size by Region
        9.4.1 APAC Human Coagulation Factor VII Revenue by Region: 2019 VS 2023 VS 2030
        9.4.2 APAC Human Coagulation Factor VII Revenue by Region (2019-2030)
        9.4.3 APAC Human Coagulation Factor VII Sales Quantity by Region (2019-2030)
        9.4.4 Japan
        9.4.5 South Korea
        9.4.6 China Taiwan
        9.4.7 Southeast Asia
        9.4.8 India

 10 Middle East, Africa and Latin America
    10.1 Middle East, Africa and Latin America Human Coagulation Factor VII Sales by Company
        10.1.1 Middle East, Africa and Latin America Human Coagulation Factor VII Sales Quantity by Company (2019-2024)
        10.1.2 Middle East, Africa and Latin America Human Coagulation Factor VII Revenue by Company (2019-2024)
    10.2 Middle East, Africa and Latin America Human Coagulation Factor VII Market Size by Type
        10.2.1 Middle East, Africa and Latin America Human Coagulation Factor VII Sales Quantity by Type (2019-2030)
        10.2.2 Middle East, Africa and Latin America Human Coagulation Factor VII Revenue by Type (2019-2030)
    10.3 Middle East, Africa and Latin America Human Coagulation Factor VII Market Size by Application
        10.3.1 Middle East, Africa and Latin America Human Coagulation Factor VII Sales Quantity by Application (2019-2030)
        10.3.2 Middle East, Africa and Latin America Human Coagulation Factor VII Revenue by Application (2019-2030)
    10.4 Middle East, Africa and Latin America Human Coagulation Factor VII Market Size by Country
        10.4.1 Middle East, Africa and Latin America Human Coagulation Factor VII Revenue by Country: 2019 VS 2023 VS 2030
        10.4.2 Middle East, Africa and Latin America Human Coagulation Factor VII Revenue by Country (2019-2030)
        10.4.3 Middle East, Africa and Latin America Human Coagulation Factor VII Sales Quantity by Country (2019-2030)
        10.4.4 Brazil
        10.4.5 Mexico
        10.4.6 Turkey
        10.4.7 Israel
        10.4.8 GCC Countries

 11 Company Profiles
    11.1 NovoNordisk
        11.1.1 NovoNordisk Company Information
        11.1.2 NovoNordisk Overview
        11.1.3 NovoNordisk Human Coagulation Factor VII Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
        11.1.4 NovoNordisk Human Coagulation Factor VII Products and Services
        11.1.5 NovoNordisk Human Coagulation Factor VII SWOT Analysis
        11.1.6 NovoNordisk Recent Developments

 12 Value Chain and Sales Channels Analysis
    12.1 Human Coagulation Factor VII Value Chain Analysis
    12.2 Human Coagulation Factor VII Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Human Coagulation Factor VII Production Mode & Process
    12.4 Human Coagulation Factor VII Sales and Marketing
        12.4.1 Human Coagulation Factor VII Sales Channels
        12.4.2 Human Coagulation Factor VII Distributors
    12.5 Human Coagulation Factor VII Customers

 13 Market Dynamics
    13.1 Human Coagulation Factor VII Industry Trends
    13.2 Human Coagulation Factor VII Market Drivers
    13.3 Human Coagulation Factor VII Market Challenges
    13.4 Human Coagulation Factor VII Market Restraints

 14 Key Findings

 15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Recombinant Factor VIII
    Table 3. Major Manufacturers of Plasma-derived Factor VIII
    Table 4. Global Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Human Coagulation Factor VII Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Human Coagulation Factor VII Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Human Coagulation Factor VII Revenue Market Share by Region (2019-2024)
    Table 8. Global Human Coagulation Factor VII Revenue by Region (2025-2030) & (US$ Million)
    Table 9. Global Human Coagulation Factor VII Revenue Market Share by Region (2025-2030)
    Table 10. Global Human Coagulation Factor VII Sales Quantity by Region: 2019 VS 2023 VS 2030 (K Mg)
    Table 11. Global Human Coagulation Factor VII Sales by Region (2019-2024) & (K Mg)
    Table 12. Global Human Coagulation Factor VII Sales Market Share by Region (2019-2024)
    Table 13. Global Human Coagulation Factor VII Sales by Region (2025-2030) & (K Mg)
    Table 14. Global Human Coagulation Factor VII Sales Market Share by Region (2025-2030)
    Table 15. Global Human Coagulation Factor VII Sales Quantity by Manufacturers (2019-2024) & (K Mg)
    Table 16. Global Human Coagulation Factor VII Sales Quantity Share by Manufacturers (2019-2024)
    Table 17. Global Human Coagulation Factor VII Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Human Coagulation Factor VII Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Human Coagulation Factor VII Price by Manufacturers 2019-2024 (USD/Kg)
    Table 20. Global Key Players of Human Coagulation Factor VII, Industry Ranking, 2022 VS 2023
    Table 21. Global Human Coagulation Factor VII Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Human Coagulation Factor VII by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Coagulation Factor VII as of 2023)
    Table 23. Global Key Manufacturers of Human Coagulation Factor VII, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Human Coagulation Factor VII, Product Offered and Application
    Table 25. Global Key Manufacturers of Human Coagulation Factor VII, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Human Coagulation Factor VII Sales Quantity by Type (2019-2024) & (K Mg)
    Table 28. Global Human Coagulation Factor VII Sales Quantity by Type (2025-2030) & (K Mg)
    Table 29. Global Human Coagulation Factor VII Sales Quantity Share by Type (2019-2024)
    Table 30. Global Human Coagulation Factor VII Sales Quantity Share by Type (2025-2030)
    Table 31. Global Human Coagulation Factor VII Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Human Coagulation Factor VII Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Human Coagulation Factor VII Revenue Share by Type (2019-2024)
    Table 34. Global Human Coagulation Factor VII Revenue Share by Type (2025-2030)
    Table 35. Human Coagulation Factor VII Price by Type (2019-2024) & (USD/Kg)
    Table 36. Global Human Coagulation Factor VII Price Forecast by Type (2025-2030) & (USD/Kg)
    Table 37. Global Human Coagulation Factor VII Sales Quantity by Application (2019-2024) & (K Mg)
    Table 38. Global Human Coagulation Factor VII Sales Quantity by Application (2025-2030) & (K Mg)
    Table 39. Global Human Coagulation Factor VII Sales Quantity Share by Application (2019-2024)
    Table 40. Global Human Coagulation Factor VII Sales Quantity Share by Application (2025-2030)
    Table 41. Global Human Coagulation Factor VII Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Human Coagulation Factor VII Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Human Coagulation Factor VII Revenue Share by Application (2019-2024)
    Table 44. Global Human Coagulation Factor VII Revenue Share by Application (2025-2030)
    Table 45. Human Coagulation Factor VII Price by Application (2019-2024) & (USD/Kg)
    Table 46. Global Human Coagulation Factor VII Price Forecast by Application (2025-2030) & (USD/Kg)
    Table 47. North America Human Coagulation Factor VII Revenue by Company (2019-2024) & (US$ Million)
    Table 48. North America Human Coagulation Factor VII Sales Quantity by Company (2019-2024) & (K Mg)
    Table 49. North America Human Coagulation Factor VII Sales Quantity by Type (2019-2024) & (K Mg)
    Table 50. North America Human Coagulation Factor VII Sales Quantity by Type (2025-2030) & (K Mg)
    Table 51. North America Human Coagulation Factor VII Revenue by Type (2019-2024) & (US$ Million)
    Table 52. North America Human Coagulation Factor VII Revenue by Type (2025-2030) & (US$ Million)
    Table 53. North America Human Coagulation Factor VII Sales Quantity by Application (2019-2024) & (K Mg)
    Table 54. North America Human Coagulation Factor VII Sales Quantity by Application (2025-2030) & (K Mg)
    Table 55. North America Human Coagulation Factor VII Revenue by Application (2019-2024) & (US$ Million)
    Table 56. North America Human Coagulation Factor VII Revenue by Application (2025-2030) & (US$ Million)
    Table 57. North America Human Coagulation Factor VII Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 58. North America Human Coagulation Factor VII Revenue by Country (2019-2024) & (US$ Million)
    Table 59. North America Human Coagulation Factor VII Revenue by Country (2025-2030) & (US$ Million)
    Table 60. North America Human Coagulation Factor VII Sales Quantity by Country (2019-2024) & (K Mg)
    Table 61. North America Human Coagulation Factor VII Sales Quantity by Country (2025-2030) & (K Mg)
    Table 62. Europe Human Coagulation Factor VII Sales Quantity by Company (2019-2024) & (K Mg)
    Table 63. Europe Human Coagulation Factor VII Revenue by Company (2019-2024) & (US$ Million)
    Table 64. Europe Human Coagulation Factor VII Sales Quantity by Type (2019-2024) & (K Mg)
    Table 65. Europe Human Coagulation Factor VII Sales Quantity by Type (2025-2030) & (K Mg)
    Table 66. Europe Human Coagulation Factor VII Revenue by Type (2019-2024) & (US$ Million)
    Table 67. Europe Human Coagulation Factor VII Revenue by Type (2025-2030) & (US$ Million)
    Table 68. Europe Human Coagulation Factor VII Sales Quantity by Application (2019-2024) & (K Mg)
    Table 69. Europe Human Coagulation Factor VII Sales Quantity by Application (2025-2030) & (K Mg)
    Table 70. Europe Human Coagulation Factor VII Revenue by Application (2019-2024) & (US$ Million)
    Table 71. Europe Human Coagulation Factor VII Revenue by Application (2025-2030) & (US$ Million)
    Table 72. Europe Human Coagulation Factor VII Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 73. Europe Human Coagulation Factor VII Revenue by Country (2019-2024) & (US$ Million)
    Table 74. Europe Human Coagulation Factor VII Revenue by Country (2025-2030) & (US$ Million)
    Table 75. Europe Human Coagulation Factor VII Sales Quantity by Country (2019-2024) & (K Mg)
    Table 76. Europe Human Coagulation Factor VII Sales Quantity by Country (2025-2030) & (K Mg)
    Table 77. China Human Coagulation Factor VII Sales Quantity by Company (2019-2024) & (K Mg)
    Table 78. China Human Coagulation Factor VII Revenue by Company (2019-2024) & (US$ Million)
    Table 79. China Human Coagulation Factor VII Sales Quantity by Type (2019-2024) & (K Mg)
    Table 80. China Human Coagulation Factor VII Sales Quantity by Type (2025-2030) & (K Mg)
    Table 81. China Human Coagulation Factor VII Revenue by Type (2019-2024) & (US$ Million)
    Table 82. China Human Coagulation Factor VII Revenue by Type (2025-2030) & (US$ Million)
    Table 83. China Human Coagulation Factor VII Sales Quantity by Application (2019-2024) & (K Mg)
    Table 84. China Human Coagulation Factor VII Sales Quantity by Application (2025-2030) & (K Mg)
    Table 85. China Human Coagulation Factor VII Revenue by Application (2019-2024) & (US$ Million)
    Table 86. China Human Coagulation Factor VII Revenue by Application (2025-2030) & (US$ Million)
    Table 87. APAC Human Coagulation Factor VII Sales Quantity by Company (2019-2024) & (K Mg)
    Table 88. APAC Human Coagulation Factor VII Revenue by Company (2019-2024) & (US$ Million)
    Table 89. APAC Human Coagulation Factor VII Sales Quantity by Type (2019-2024) & (K Mg)
    Table 90. APAC Human Coagulation Factor VII Sales Quantity by Type (2025-2030) & (K Mg)
    Table 91. APAC Human Coagulation Factor VII Revenue by Type (2019-2024) & (US$ Million)
    Table 92. APAC Human Coagulation Factor VII Revenue by Type (2025-2030) & (US$ Million)
    Table 93. APAC Human Coagulation Factor VII Sales Quantity by Application (2019-2024) & (K Mg)
    Table 94. APAC Human Coagulation Factor VII Sales Quantity by Application (2025-2030) & (K Mg)
    Table 95. APAC Human Coagulation Factor VII Revenue by Application (2019-2024) & (US$ Million)
    Table 96. APAC Human Coagulation Factor VII Revenue by Application (2025-2030) & (US$ Million)
    Table 97. APAC Human Coagulation Factor VII Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 98. APAC Human Coagulation Factor VII Revenue by Region (2019-2024) & (US$ Million)
    Table 99. APAC Human Coagulation Factor VII Revenue by Region (2025-2030) & (US$ Million)
    Table 100. APAC Human Coagulation Factor VII Sales Quantity by Region (2019-2024) & (K Mg)
    Table 101. APAC Human Coagulation Factor VII Sales Quantity by Region (2025-2030) & (K Mg)
    Table 102. Middle East, Africa and Latin America Human Coagulation Factor VII Sales Quantity by Company (2019-2024) & (K Mg)
    Table 103. Middle East, Africa and Latin America Human Coagulation Factor VII Revenue by Company (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Human Coagulation Factor VII Sales Quantity by Type (2019-2024) & (K Mg)
    Table 105. Middle East, Africa and Latin America Human Coagulation Factor VII Sales Quantity by Type (2025-2030) & (K Mg)
    Table 106. Middle East, Africa and Latin America Human Coagulation Factor VII Revenue by Type (2019-2024) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Human Coagulation Factor VII Revenue by Type (2025-2030) & (US$ Million)
    Table 108. Middle East, Africa and Latin America Human Coagulation Factor VII Sales Quantity by Application (2019-2024) & (K Mg)
    Table 109. Middle East, Africa and Latin America Human Coagulation Factor VII Sales Quantity by Application (2025-2030) & (K Mg)
    Table 110. Middle East, Africa and Latin America Human Coagulation Factor VII Revenue by Application (2019-2024) & (US$ Million)
    Table 111. Middle East, Africa and Latin America Human Coagulation Factor VII Revenue by Application (2025-2030) & (US$ Million)
    Table 112. Middle East, Africa and Latin America Human Coagulation Factor VII Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 113. Middle East, Africa and Latin America Human Coagulation Factor VII Revenue by Country (2019-2024) & (US$ Million)
    Table 114. Middle East, Africa and Latin America Human Coagulation Factor VII Revenue by Country (2025-2030) & (US$ Million)
    Table 115. Middle East, Africa and Latin America Human Coagulation Factor VII Sales Quantity by Country (2019-2024) & (K Mg)
    Table 116. Middle East, Africa and Latin America Human Coagulation Factor VII Sales Quantity by Country (2025-2030) & (K Mg)
    Table 117. NovoNordisk Company Information
    Table 118. NovoNordisk Description and Overview
    Table 119. NovoNordisk Human Coagulation Factor VII Sales Quantity (K Mg), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2019-2024)
    Table 120. NovoNordisk Human Coagulation Factor VII Product and Services
    Table 121. NovoNordisk Human Coagulation Factor VII SWOT Analysis
    Table 122. NovoNordisk Recent Developments
    Table 123. Key Raw Materials Lists
    Table 124. Raw Materials Key Suppliers Lists
    Table 125. Human Coagulation Factor VII Distributors List
    Table 126. Human Coagulation Factor VII Customers List
    Table 127. Human Coagulation Factor VII Market Trends
    Table 128. Human Coagulation Factor VII Market Drivers
    Table 129. Human Coagulation Factor VII Market Challenges
    Table 130. Human Coagulation Factor VII Market Restraints
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Coagulation Factor VII Product Picture
    Figure 2. Global Human Coagulation Factor VII Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Human Coagulation Factor VII Market Share by Type in 2023 & 2030
    Figure 4. Recombinant Factor VIII Product Picture
    Figure 5. Plasma-derived Factor VIII Product Picture
    Figure 6. Global Human Coagulation Factor VII Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Human Coagulation Factor VII Market Share by Application in 2023 & 2030
    Figure 8. Hemophilia A
    Figure 9. Spontanous / Trauma
    Figure 10. Surgical
    Figure 11. Others
    Figure 12. Human Coagulation Factor VII Report Years Considered
    Figure 13. Global Human Coagulation Factor VII Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Human Coagulation Factor VII Revenue 2019-2030 (US$ Million)
    Figure 15. Global Human Coagulation Factor VII Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 16. Global Human Coagulation Factor VII Sales Quantity 2019-2030 (K Mg)
    Figure 17. Global Human Coagulation Factor VII Sales Quantity Market Share by Region (2019-2024)
    Figure 18. Global Human Coagulation Factor VII Sales Quantity Market Share by Region (2025-2030)
    Figure 19. North America Human Coagulation Factor VII Sales Quantity YoY (2019-2030) & (K Mg)
    Figure 20. North America Human Coagulation Factor VII Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. Europe Human Coagulation Factor VII Sales Quantity YoY (2019-2030) & (K Mg)
    Figure 22. Europe Human Coagulation Factor VII Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. China Human Coagulation Factor VII Sales Quantity YoY (2019-2030) & (K Mg)
    Figure 24. China Human Coagulation Factor VII Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. APAC Human Coagulation Factor VII Sales Quantity YoY (2019-2030) & (K Mg)
    Figure 26. APAC Human Coagulation Factor VII Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Human Coagulation Factor VII Sales Quantity YoY (2019-2030) & (K Mg)
    Figure 28. Middle East, Africa and Latin America Human Coagulation Factor VII Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. The Top 10 and Top 5 Players Market Share by Human Coagulation Factor VII Sales Quantity in 2023
    Figure 30. The Top 10 and Top 5 Players Market Share by Human Coagulation Factor VII Revenue in 2023
    Figure 31. Human Coagulation Factor VII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 32. Global Human Coagulation Factor VII Sales Quantity Market Share by Type (2019-2030)
    Figure 33. Global Human Coagulation Factor VII Revenue Market Share by Type (2019-2030)
    Figure 34. Global Human Coagulation Factor VII Sales Quantity Market Share by Application (2019-2030)
    Figure 35. Global Human Coagulation Factor VII Revenue Market Share by Application (2019-2030)
    Figure 36. North America Human Coagulation Factor VII Revenue Market Share by Company in 2023
    Figure 37. North America Human Coagulation Factor VII Sales Quantity Market Share by Company in 2023
    Figure 38. North America Human Coagulation Factor VII Sales Quantity Market Share by Type (2019-2030)
    Figure 39. North America Human Coagulation Factor VII Revenue Market Share by Type (2019-2030)
    Figure 40. North America Human Coagulation Factor VII Sales Quantity Market Share by Application (2019-2030)
    Figure 41. North America Human Coagulation Factor VII Revenue Market Share by Application (2019-2030)
    Figure 42. North America Human Coagulation Factor VII Revenue Share by Country (2019-2030)
    Figure 43. North America Human Coagulation Factor VII Sales Quantity Share by Country (2019-2030)
    Figure 44. U.S. Human Coagulation Factor VII Revenue (2019-2030) & (US$ Million)
    Figure 45. Canada Human Coagulation Factor VII Revenue (2019-2030) & (US$ Million)
    Figure 46. Europe Human Coagulation Factor VII Sales Quantity Market Share by Company in 2023
    Figure 47. Europe Human Coagulation Factor VII Revenue Market Share by Company in 2023
    Figure 48. Europe Human Coagulation Factor VII Sales Quantity Market Share by Type (2019-2030)
    Figure 49. Europe Human Coagulation Factor VII Revenue Market Share by Type (2019-2030)
    Figure 50. Europe Human Coagulation Factor VII Sales Quantity Market Share by Application (2019-2030)
    Figure 51. Europe Human Coagulation Factor VII Revenue Market Share by Application (2019-2030)
    Figure 52. Europe Human Coagulation Factor VII Revenue Share by Country (2019-2030)
    Figure 53. Europe Human Coagulation Factor VII Sales Quantity Share by Country (2019-2030)
    Figure 54. Germany Human Coagulation Factor VII Revenue (2019-2030) & (US$ Million)
    Figure 55. France Human Coagulation Factor VII Revenue (2019-2030) & (US$ Million)
    Figure 56. U.K. Human Coagulation Factor VII Revenue (2019-2030) & (US$ Million)
    Figure 57. Italy Human Coagulation Factor VII Revenue (2019-2030) & (US$ Million)
    Figure 58. Russia Human Coagulation Factor VII Revenue (2019-2030) & (US$ Million)
    Figure 59. China Human Coagulation Factor VII Sales Quantity Market Share by Company in 2023
    Figure 60. China Human Coagulation Factor VII Revenue Market Share by Company in 2023
    Figure 61. China Human Coagulation Factor VII Sales Quantity Market Share by Type (2019-2030)
    Figure 62. China Human Coagulation Factor VII Revenue Market Share by Type (2019-2030)
    Figure 63. China Human Coagulation Factor VII Sales Quantity Market Share by Application (2019-2030)
    Figure 64. China Human Coagulation Factor VII Revenue Market Share by Application (2019-2030)
    Figure 65. APAC Human Coagulation Factor VII Sales Quantity Market Share by Company in 2023
    Figure 66. APAC Human Coagulation Factor VII Revenue Market Share by Company in 2023
    Figure 67. APAC Human Coagulation Factor VII Sales Quantity Market Share by Type (2019-2030)
    Figure 68. APAC Human Coagulation Factor VII Revenue Market Share by Type (2019-2030)
    Figure 69. APAC Human Coagulation Factor VII Sales Quantity Market Share by Application (2019-2030)
    Figure 70. APAC Human Coagulation Factor VII Revenue Market Share by Application (2019-2030)
    Figure 71. APAC Human Coagulation Factor VII Revenue Share by Region (2019-2030)
    Figure 72. APAC Human Coagulation Factor VII Sales Quantity Share by Region (2019-2030)
    Figure 73. Japan Human Coagulation Factor VII Revenue (2019-2030) & (US$ Million)
    Figure 74. South Korea Human Coagulation Factor VII Revenue (2019-2030) & (US$ Million)
    Figure 75. China Taiwan Human Coagulation Factor VII Revenue (2019-2030) & (US$ Million)
    Figure 76. Southeast Asia Human Coagulation Factor VII Revenue (2019-2030) & (US$ Million)
    Figure 77. India Human Coagulation Factor VII Revenue (2019-2030) & (US$ Million)
    Figure 78. Middle East, Africa and Latin America Human Coagulation Factor VII Sales Quantity Market Share by Company in 2023
    Figure 79. Middle East, Africa and Latin America Human Coagulation Factor VII Revenue Market Share by Company in 2023
    Figure 80. Middle East, Africa and Latin America Human Coagulation Factor VII Sales Quantity Market Share by Type (2019-2030)
    Figure 81. Middle East, Africa and Latin America Human Coagulation Factor VII Revenue Market Share by Type (2019-2030)
    Figure 82. Middle East, Africa and Latin America Human Coagulation Factor VII Sales Quantity Market Share by Application (2019-2030)
    Figure 83. Middle East, Africa and Latin America Human Coagulation Factor VII Revenue Market Share by Application (2019-2030)
    Figure 84. Middle East, Africa and Latin America Human Coagulation Factor VII Sales Quantity Share by Country (2019-2030)
    Figure 85. Middle East, Africa and Latin America Human Coagulation Factor VII Revenue Share by Country (2019-2030)
    Figure 86. Brazil Human Coagulation Factor VII Revenue (2019-2030) & (US$ Million)
    Figure 87. Mexico Human Coagulation Factor VII Revenue (2019-2030) & (US$ Million)
    Figure 88. Turkey Human Coagulation Factor VII Revenue (2019-2030) & (US$ Million)
    Figure 89. Israel Human Coagulation Factor VII Revenue (2019-2030) & (US$ Million)
    Figure 90. GCC Countries Human Coagulation Factor VII Revenue (2019-2030) & (US$ Million)
    Figure 91. Human Coagulation Factor VII Value Chain
    Figure 92. Human Coagulation Factor VII Production Process
    Figure 93. Channels of Distribution (Direct Vs Distribution)
    Figure 94. Distributors Profiles
    Figure 95. Bottom-up and Top-down Approaches for This Report
    Figure 96. Data Triangulation
    Figure 97. Key Executives Interviewed

Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activated factor VII is also available, but does not play any considerable role in the market.

The global Human Coagulation Factor VII market size was US$ 2282.4 million in 2023 and is forecast to a readjusted size of US$ 4368 million by 2030 with a CAGR of 9.6% during the forecast period 2024-2030.

Europe and North America are the largest region of Human Coagulation Factor VII, with about 40% market share respectively. NovoNordisk is the major manufacturer of industry.

In terms of sales (consumption) side, this report focuses on the sales of Human Coagulation Factor VII by regions (Countries), company, by type and by type. from 2019 to 2024 and forecast to 2030.

The global Human Coagulation Factor VII market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Human Coagulation Factor VII market. These figures have been provided in terms of both revenue and sales for the period 2019-2030. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.

Market Segmentation

Industry: Pharma & Healthcare

Published: 2024-04-17

Pages: 118 Pages

Report ld: 2697328

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 5600.00

Multi Users License

USD 8400.00

Corporate Users License